| SEAGEN INC. DL-,001 | 139.080 / +2.67% |
| Date/Time | 09/21 / 09:43 |
| Chg. / Chg.(%) | 3.620 / +2.67% |
| Bid | 138.980 / 54 |
| Ask | 141.000 / 54 |
| Open | 138.240 |
| Previous Close | 135.460 |
| High | 139.080 |
| Low | 138.240 |
| Volume [EUR] | - |
| Volume [Units] | |
| Price fixings | 3 |
| ISIN | US81181C1045 |
| Security | SGT |
| Exchange | gettex |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| TradeGate | 141.00 |  |
11 |
| München | 138.28 | |
0 |
| Berlin | 138.32 | |
0 |
| Frankfurt | 139.0600 | |
0 |
| Quotrix | 139.2400 | |
|
| Stuttgart | 139.120 | |
|
| Lang & Schwa.. | 139.12 | |
|
| gettex | 139.080 | |
|
| NASDAQ | 159.0600 | |
1,206,050 |
| IEX | 159.13 | |
82,333 |
| Cboe US | 159.09 | |
32,158 |
| London Domes.. | 158.92 | 371 | |
| Mexico | 3,026.00 |  |
17 |
News
- Genmab and Seagen Announce FDA Accelerated Approval for TIVDAK™ (tisotumab vedotin-tftv) in Previously Treated Recurrent or Metastatic Cervical Cancer
09/20/2021 / 23:00 - GlobeNewswire - Icosavax Reports Second Quarter 2021 Financial Results and Provides Corporate Update
09/13/2021 / 22:05 - GlobeNewswire - Icosavax Appoints Elizabeth Bekiroğlu to General Counsel
09/10/2021 / 14:00 - GlobeNewswire - Neoleukin Therapeutics Announces Appointment of Bill Arthur, Ph.D., as Vice President and Head of Research
09/09/2021 / 14:00 - GlobeNewswire - Pyxis Oncology Strengthens Board of Directors
09/08/2021 / 14:00 - GlobeNewswire
Personal area
Real-timeClick on 
to activate push quotes.
to activate push quotes.